Bromophenol is a type of natural marine product. It has excellent
biological activities, especially anticancer activities. In our study of searching for potent anticancer drugs, a novel bromophenol derivative containing
indolin-2-one moiety, 3-(4-(3-([1,4'-bipiperidin]-1'-yl)propoxy)-3-bromo-5-methoxybenzylidene)-N-(4-bromophenyl)-2-oxoindoline-5-
sulfonamide (BOS-102) was synthesized, which showed excellent anticancer activities on human
lung cancer cell lines. A study of the mechanisms indicated that
BOS-102 could significantly block cell proliferation in human A549
lung cancer cells and effectively induce G0/G1 cell cycle arrest via targeting
cyclin D1 and
cyclin-dependent kinase 4 (CDK4).
BOS-102 could also induce apoptosis, including activating
caspase-3 and
poly (ADP-ribose) polymerase (PARP), increasing the Bax/Bcl-2 ratio, enhancing
reactive oxygen species (ROS) generation, decreasing mitochondrial membrane potential (
MMP, ΔΨm), and leading
cytochrome c release from mitochondria. Further research revealed that
BOS-102 deactivated the PI3K/Akt pathway and activated the
mitogen-activated protein kinase (MAPK) signaling pathway resulting in apoptosis and cell cycle arrest, which indicated that
BOS-102 has the potential to develop into an anticancer
drug.